Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated:  11/9/2012
ImClone Investigational Site
mi
from
Dallas, TX
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated: 11/9/2012
ImClone Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated:  11/9/2012
ImClone Investigational Site
mi
from
Rutland, VT
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated: 11/9/2012
ImClone Investigational Site
mi
from
Rutland, VT
Click here to add this to my saved trials
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated:  11/9/2012
ImClone Investigational Site
mi
from
Fairfax, VA
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated: 11/9/2012
ImClone Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated:  11/9/2012
ImClone Investigational Site
mi
from
Everett, WA
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy
Status: Enrolling
Updated: 11/9/2012
ImClone Investigational Site
mi
from
Everett, WA
Click here to add this to my saved trials
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Status: Enrolling
Updated:  11/12/2012
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Status: Enrolling
Updated: 11/12/2012
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Status: Enrolling
Updated:  11/12/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Status: Enrolling
Updated: 11/12/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Chemotherapeutic Agents in Brain/Breast
Clinical Study to Assess Entry of Chemotherapeutic Agents Into Brain Metastases in Women With Breast Cancer
Status: Enrolling
Updated:  11/13/2012
Memorial Sloan Kettering
mi
from
New York City, NY
Chemotherapeutic Agents in Brain/Breast
Clinical Study to Assess Entry of Chemotherapeutic Agents Into Brain Metastases in Women With Breast Cancer
Status: Enrolling
Updated: 11/13/2012
Memorial Sloan Kettering
mi
from
New York City, NY
Click here to add this to my saved trials
Chemotherapeutic Agents in Brain/Breast
Clinical Study to Assess Entry of Chemotherapeutic Agents Into Brain Metastases in Women With Breast Cancer
Status: Enrolling
Updated:  11/13/2012
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Chemotherapeutic Agents in Brain/Breast
Clinical Study to Assess Entry of Chemotherapeutic Agents Into Brain Metastases in Women With Breast Cancer
Status: Enrolling
Updated: 11/13/2012
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis
Effect of Topical Application of Sulforaphane- Containing Broccoli Sprout Extracts on Radiation Dermatitis During External-beam Radiation Therapy for Breast Cancer
Status: Enrolling
Updated:  11/15/2012
Johns Hopkins University
mi
from
Baltimore, MD
Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis
Effect of Topical Application of Sulforaphane- Containing Broccoli Sprout Extracts on Radiation Dermatitis During External-beam Radiation Therapy for Breast Cancer
Status: Enrolling
Updated: 11/15/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Early Detection of Breast Cancer Using Tomosynthesis Imaging
Early Detection of Breast Cancer Using Tomosynthesis Imaging
Status: Enrolling
Updated:  11/16/2012
DUMC Mammography, Duke South Hospital, 2nd floor
mi
from
Durham, NC
Early Detection of Breast Cancer Using Tomosynthesis Imaging
Early Detection of Breast Cancer Using Tomosynthesis Imaging
Status: Enrolling
Updated: 11/16/2012
DUMC Mammography, Duke South Hospital, 2nd floor
mi
from
Durham, NC
Click here to add this to my saved trials
The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction
The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Autologous Tissue Reconstruction - A Pilot Study
Status: Enrolling
Updated:  11/26/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction
The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Autologous Tissue Reconstruction - A Pilot Study
Status: Enrolling
Updated: 11/26/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy
Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy.
Status: Enrolling
Updated:  11/27/2012
University of Pittsburgh
mi
from
Pittsburgh, PA
Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy
Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy.
Status: Enrolling
Updated: 11/27/2012
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
Evaluation of Contrast-enhanced Mammography and Contrast-enhanced Breast Tomosynthesis: Comparison to Contrast-enhanced Breast MRI- A Pilot Study
Status: Enrolling
Updated:  11/30/2012
Rose Medical Center
mi
from
Denver, CO
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
Evaluation of Contrast-enhanced Mammography and Contrast-enhanced Breast Tomosynthesis: Comparison to Contrast-enhanced Breast MRI- A Pilot Study
Status: Enrolling
Updated: 11/30/2012
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Status: Enrolling
Updated:  12/1/2012
University of Michigan
mi
from
Ann Arbor, MI
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Status: Enrolling
Updated: 12/1/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Status: Enrolling
Updated:  12/1/2012
University of Michigan
mi
from
Ann Arbor, MI
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
Status: Enrolling
Updated: 12/1/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
University of Mississippi Medical Center Research Institute
mi
from
Jackson, MS
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
University of Mississippi Medical Center Research Institute
mi
from
Jackson, MS
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
Hershey Medical Center
mi
from
Hershey, PA
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
MBCCOP - Meharry Medical College - Nashville
mi
from
Nashville, TN
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
MBCCOP - Meharry Medical College - Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
The Methodist Hospital Research Institute
mi
from
Houston, TX
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
The Methodist Hospital Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated:  12/6/2012
University of Virginia Health Sciences Center
mi
from
Charlottesville, VA
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients With Triple-negative Locally Advanced Breast Cancer.
Status: Enrolling
Updated: 12/6/2012
University of Virginia Health Sciences Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Cone Beam Computed Tomography for Breast Imaging
Cone Beam Computed Tomography for Breast Imaging
Status: Enrolling
Updated:  12/13/2012
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Cone Beam Computed Tomography for Breast Imaging
Cone Beam Computed Tomography for Breast Imaging
Status: Enrolling
Updated: 12/13/2012
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Click here to add this to my saved trials
Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Exploratory Study of Topical Norepinephrine in Post-Surgical Breast Cancer Patients Receiving Radiotherapy
Status: Enrolling
Updated:  12/18/2012
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Exploratory Study of Topical Norepinephrine in Post-Surgical Breast Cancer Patients Receiving Radiotherapy
Status: Enrolling
Updated: 12/18/2012
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
A Phase II Study of Abraxane® and Carboplatin as First-line Treatment for "Triple Negative" (Demonstrating no Expression for Estrogen, Progesterone, or Human Epidermal Growth Factor Receptor 2 (HER2)Receptors) Metastatic Breast Cancer
Status: Enrolling
Updated:  12/28/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
A Phase II Study of Abraxane® and Carboplatin as First-line Treatment for "Triple Negative" (Demonstrating no Expression for Estrogen, Progesterone, or Human Epidermal Growth Factor Receptor 2 (HER2)Receptors) Metastatic Breast Cancer
Status: Enrolling
Updated: 12/28/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Status: Enrolling
Updated:  1/3/2013
Leo W. Jenkins Cancer Center
mi
from
Greenville, NC
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 1/3/2013
Leo W. Jenkins Cancer Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
Tumescent Mastectomy: A Prospective Comparison to Standard Mastectomy Technique
Status: Enrolling
Updated:  1/15/2013
University of California Davis Cancer Center
mi
from
Sacramento, CA
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
Tumescent Mastectomy: A Prospective Comparison to Standard Mastectomy Technique
Status: Enrolling
Updated: 1/15/2013
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  1/17/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 1/17/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Status: Enrolling
Updated:  1/18/2013
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Status: Enrolling
Updated: 1/18/2013
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
A Phase I Dose Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy With Biomarker Analysis in Patients With HER2-Overexpressing Breast Cancer
Status: Enrolling
Updated:  1/22/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
A Phase I Dose Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy With Biomarker Analysis in Patients With HER2-Overexpressing Breast Cancer
Status: Enrolling
Updated: 1/22/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Percutaneous Removal and Margin Ablation for Breast Cancer
Percutaneous Removal and Margin Ablation for Breast Cancer
Status: Enrolling
Updated:  1/23/2013
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Percutaneous Removal and Margin Ablation for Breast Cancer
Percutaneous Removal and Margin Ablation for Breast Cancer
Status: Enrolling
Updated: 1/23/2013
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Status: Enrolling
Updated:  1/23/2013
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Status: Enrolling
Updated: 1/23/2013
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
Status: Enrolling
Updated:  1/23/2013
University of Colorado, College of Nursing
mi
from
Aurora, CO
Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
Status: Enrolling
Updated: 1/23/2013
University of Colorado, College of Nursing
mi
from
Aurora, CO
Click here to add this to my saved trials
CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Status: Enrolling
Updated:  1/23/2013
OHSU Knight Cancer Institute
mi
from
Portland, OR
CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Status: Enrolling
Updated: 1/23/2013
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Status: Enrolling
Updated:  2/11/2013
Columbia University Medical Center
mi
from
New York, NY
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer
Status: Enrolling
Updated: 2/11/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
Status: Enrolling
Updated:  2/13/2013
Nebraska Cancer Specialists/Midwest Cancer Center - Legacy
mi
from
Omaha, NE
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
Status: Enrolling
Updated: 2/13/2013
Nebraska Cancer Specialists/Midwest Cancer Center - Legacy
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Montefiore Medical Center
mi
from
Bronx, NY
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Oregon Health and Science University
mi
from
Portland, OR
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Huntsman Cancer Institute
mi
from
Salt Lake, UT
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Huntsman Cancer Institute
mi
from
Salt Lake, UT
Click here to add this to my saved trials
Nutrition, Exercise, and Breast Cancer Survivorship
Impact of Nutrition and Exercise on Glucose Metabolism, Inflammation, and Body Composition in Older Breast Cancer Survivors
Status: Enrolling
Updated:  2/21/2013
Baltimore VAMC
mi
from
Baltimore, MD
Nutrition, Exercise, and Breast Cancer Survivorship
Impact of Nutrition and Exercise on Glucose Metabolism, Inflammation, and Body Composition in Older Breast Cancer Survivors
Status: Enrolling
Updated: 2/21/2013
Baltimore VAMC
mi
from
Baltimore, MD
Click here to add this to my saved trials
DIBH Proton Planning
A Prospective Radiation Oncology Planning Study For Lung, Gastrointestinal And Lymphomatous Malignancies Using Proton Radiotherapy As Compared To 3D Conformal And Intensity-Modulated X-Ray Therapy For Dosimetric Evaluation Of Tumoral Coverage And Dose To Organs-At-Risk.
Status: Enrolling
Updated:  2/25/2013
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
DIBH Proton Planning
A Prospective Radiation Oncology Planning Study For Lung, Gastrointestinal And Lymphomatous Malignancies Using Proton Radiotherapy As Compared To 3D Conformal And Intensity-Modulated X-Ray Therapy For Dosimetric Evaluation Of Tumoral Coverage And Dose To Organs-At-Risk.
Status: Enrolling
Updated: 2/25/2013
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated:  3/1/2013
University of Kansas Cancer Center Medical Center
mi
from
Kansas City, KA
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated: 3/1/2013
University of Kansas Cancer Center Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated:  3/1/2013
Henry Ford Hospital Henry Ford
mi
from
Detroit, MI
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Henry Ford Hospital Henry Ford
mi
from
Detroit, MI
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated:  3/1/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated:  3/1/2013
Comprehensive Cancer Centers
mi
from
Las Vegas, NV
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Comprehensive Cancer Centers
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated:  3/1/2013
Cancer Institute of New Jersey Dept of Cancer Institute of NJ
mi
from
New Brunswick, NJ
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Cancer Institute of New Jersey Dept of Cancer Institute of NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials